Glucotrack, Inc. financial data

Symbol
GCTK on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
301 Rt 17 North, Suite 800, Rutherford, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Integrity Applications, Inc. (to 12/9/2021)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 79.7 % -81.8%
Debt-to-equity -148 % -518%
Return On Equity 453 %
Return On Assets -954 % -651%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.6M shares -4.38%
Common Stock, Shares, Outstanding 792K shares +279%
Entity Public Float 8.6M USD +60.4%
Common Stock, Value, Issued 1K USD -75%
Weighted Average Number of Shares Outstanding, Basic 330K shares +59%
Weighted Average Number of Shares Outstanding, Diluted 330K shares +59%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 9.5M USD +102%
Selling and Marketing Expense 70K USD
General and Administrative Expense 4.66M USD +104%
Operating Income (Loss) -14.5M USD -105%
Net Income (Loss) Attributable to Parent -22.6M USD -218%
Earnings Per Share, Basic 68.4 USD/shares +100%
Earnings Per Share, Diluted 68.4 USD/shares +100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.62M USD +25%
Other Assets, Current 151K USD -59.8%
Assets, Current 5.77M USD +18.5%
Property, Plant and Equipment, Net 95K USD +252%
Operating Lease, Right-of-Use Asset 59K USD
Assets 5.93M USD +20.9%
Accounts Payable, Current 992K USD +18.2%
Liabilities, Current 1.28M USD -15.7%
Operating Lease, Liability, Noncurrent 33K USD
Other Liabilities, Noncurrent 203K USD +3.57%
Liabilities 18.9M USD +1008%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8K USD -150%
Retained Earnings (Accumulated Deficit) -132M USD -20.6%
Stockholders' Equity Attributable to Parent -13M USD -507%
Liabilities and Equity 5.93M USD +20.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.94M USD -124%
Net Cash Provided by (Used in) Investing Activities -59K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 792K shares +279%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3M USD -127%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.63M USD +25%
Interest Paid, Excluding Capitalized Interest, Operating Activities 28K USD
Deferred Tax Assets, Gross 20.5M USD +52%
Operating Lease, Liability 59K USD
Depreciation 4K USD -55.6%
Payments to Acquire Property, Plant, and Equipment 59K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -22.6M USD -218%
Lessee, Operating Lease, Liability, to be Paid 65K USD
Operating Lease, Liability, Current 26K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD
Deferred Tax Assets, Operating Loss Carryforwards 17M USD +37.3%
Operating Lease, Payments 3K USD
Additional Paid in Capital 855K USD
Depreciation, Depletion and Amortization 4K USD 0%
Interest Expense 5K USD